| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.49 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |